mirtazapine has been researched along with aripiprazole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baghai, TC; Born, C; Eser, D; Häfner, S; Hecht, S; Hermisson, I; Nothdurfter, C; Rupprecht, R; Schüle, C | 1 |
| Dimopoulos, NP; Mitsonis, CI; Psarra, VV | 1 |
| Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N | 1 |
| Guerdjikova, A; Keck, PE; McElroy, SL; Mori, N | 1 |
| Christoffersen, RK; Høimark, L; Vesterby, A; Vestergård, LD | 1 |
| Bergman, J; Pashinian, A; Poyurovsky, M; Weizman, A | 1 |
| Khouzam, HR | 1 |
| Akbas, B; Akca, OF | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Balcı, N; Demir, Y; Gürbüz, M; Küfrevioğlu, Öİ; Özaslan, MS | 1 |
| Kaminska, K; Lech, MA; Lorenc-Koci, E; Rogoz, Z; Wasik, A | 1 |
| Oravecz, R; Stuhec, M | 1 |
4 review(s) available for mirtazapine and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic potential of new second generation antipsychotics for major depressive disorder.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic | 2010 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Bupropion XL unapproved use in the prisons: Two cases focused on the bupropion pharmacology.
Topics: Adult; Aripiprazole; Bupropion; Depressive Disorder, Major; Dopamine; Humans; Mirtazapine; Norepinephrine; Prisons; Quetiapine Fumarate; Randomized Controlled Trials as Topic | 2022 |
2 trial(s) available for mirtazapine and aripiprazole
| Article | Year |
|---|---|
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Personality Inventory; Piperazines; Quinolones | 2007 |
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Serotonin; Treatment Outcome | 2009 |
10 other study(ies) available for mirtazapine and aripiprazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Employment; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Piperazines; Quinolones; Schizophrenia, Paranoid; Social Behavior | 2008 |
[Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics].
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Autopsy; Benzodiazepines; Death, Sudden, Cardiac; Drug Therapy, Combination; Eosinophilia; Forensic Pathology; Forensic Toxicology; Humans; Male; Mianserin; Mirtazapine; Myocarditis; Myocardium; Olanzapine; Piperazines; Quinolones; Risk Factors | 2011 |
Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dopamine D2 Receptor Antagonists; Female; Histamine H1 Antagonists; Hospitals, Psychiatric; Humans; Israel; Male; Mianserin; Middle Aged; Mirtazapine; Off-Label Use; Piperazines; Quinolones; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
Treatment of a Child with Autism Spectrum Disorder and Food Refusal Due to Restricted and Repetitive Behaviors.
Topics: Aggression; Aripiprazole; Autism Spectrum Disorder; Child; Feeding and Eating Disorders; Humans; Male; Mirtazapine; Problem Behavior | 2018 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes.
Topics: Antidepressive Agents; Aripiprazole; Citalopram; Erythrocytes; Glucosephosphate Dehydrogenase; Haloperidol; Humans; Mirtazapine; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase | 2019 |
Repeated co-treatment with mirtazapine and aripiprazole reversed the schizophrenia-like behaviors and increased the brain-derived neurotrophic factor mRNA expression in the adult Sprague-Dawley rats exposed to glutathione deficit during early postnatal br
Topics: Animals; Aripiprazole; Brain; Brain-Derived Neurotrophic Factor; Glutathione; Male; Mirtazapine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia | 2021 |